These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38669429)

  • 21. Identification of a metabolism-linked genomic signature for prognosis and immunotherapeutic efficiency in metastatic skin cutaneous melanoma.
    He Z; Lyu J; Lyu L; Long X; Xu B
    Medicine (Baltimore); 2024 Jun; 103(23):e38347. PubMed ID: 38847706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
    Wu X; Chen S; Ji Q; Chen H; Chen X
    Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients.
    Liao S; He J; Liu C; Zhang Z; Liao H; Liao Z; Yu C; Guan J; Mo H; Yuan Z; Liang T; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
    Medicine (Baltimore); 2021 Jun; 100(22):e26219. PubMed ID: 34087900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
    Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
    J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
    Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
    Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma.
    Lin W; Tan ZY; Fang XC
    SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma.
    Xiong C; Pan G; Wang H; Meng G; Yan L; Li R; Yan Y; Yang Y; Zhang X; Yang C; Dong Z; Li T
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16869-16884. PubMed ID: 37736789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of a gene signature associated with anoikis to evaluate the prognosis and immune infiltration in patients with colorectal cancer.
    Wen H; Ni X; Qian S; Abdul S; Lv H; Chen Y
    Transl Cancer Res; 2024 Apr; 13(4):1904-1923. PubMed ID: 38737694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma.
    Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G
    Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer.
    Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L
    Front Genet; 2023; 14():1186862. PubMed ID: 37323657
    [No Abstract]   [Full Text] [Related]  

  • 34. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
    Han W; Huang B; Zhao XY; Shen GL
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram based on autophagy related genes for predicting the survival in melanoma.
    Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
    BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi
    Wu M; Li K; Liao Y; Li L; Xiao X; Chen Y; Guo J; Hu F; Qu J; Wang Z; Feng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):159-174. PubMed ID: 38755712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine learning-based identification of an immunotherapy-related signature to enhance outcomes and immunotherapy responses in melanoma.
    Deng Z; Liu J; Yu YV; Jin YN
    Front Immunol; 2024; 15():1451103. PubMed ID: 39355255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
    Duan Y; Xu X
    Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of hub anoikis-associated genes and risk signature in cutaneous melanoma.
    He YW; Fan QP; Hua AL; Liu Q
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5662-5676. PubMed ID: 37401304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing a prognostic model for skin melanoma based on the persistent tumor mutation burden and determining IL17REL as a therapeutic target.
    Xu M; Ma X; Wang Y; Yu Z; Zheng X; Dai H; Xue C
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):313. PubMed ID: 38900244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.